GeekWire: A-Alpha Bio Receives Phase II NSF SBIR Grant for Molecular Glue Discovery

A-Alpha Bio today announced that it has been awarded a National Science Foundation Phase II Small Business Innovation Research (SBIR) grant to continue developing their AlphaSeq platform for the discovery of molecular glues.

GeekWire wrote a great summary article with more details about the award and about the potential impact of molecular glue discovery in medicine.

Recent Posts

See All

A-Alpha Bio Secures $20M Series A Financing!

This morning we announced that we have closed a $20M Series A Financing Round to dramatically expand our capabilities and throughput! The round was led by Madrona Venture Group, our partner since the